JAVA Information for Authors
The Journal of the Association for Vascular Access (JAVA) welcomes scholarly original articles on clinical practice, education, and research related to vascular access including articles on vascular access manufacturing and technology and vascular access insertion, care, and maintenance issues in hospitals, ambulatory, home, hospice, and other alternative care settings. Articles must not be previously published or under consideration by another journal at the time of submission. JAVA is a multidisciplinary, international journal and invites submissions from authors in all relevant disciplines and settings. Current topics of interest to the journal include: evidence-based practice, new initiatives, outcomes research, patient/family satisfaction, patient and family instruction, international and multidisciplinary issues, use of devices, implementation of new technologies, financial implications of devices, and issues confronted in clinical practice.
The journal editor and members of the Editorial Review Board will evaluate each submitted manuscript on the strength and originality of its methods, discussion, research and impact on patient safety and best practice in vascular access.
Main article categories
The following is a description of the main article categories. They include but are not limited to:
Articles in this category usually present results of original research undertaken by the author. Authors must include a structured abstract not to exceed 250 words. Structured abstracts should include Background, Methods,Results (including some data), and Conclusions. The maximum length is 6,000 words, including references, tables, photographs, and figures. The Abstract and Title page are not included in this word count. Articles that report original research should include the following headings as appropriate: Background (literature), Methods (design, data collection and analysis), Results, Discussion, Conclusions, Limitations, and Recommendations for Practice. Qualitative studies are also encouraged and should adhere to the above research guidelines as appropriate. Research articles that involved human participants require Internal Review Board (IRB) approval to be considered for publication. This should be noted in the “methods” section.
Review articles collate and summarize the available information about a particular topic. Qualitative and quantitative literature reviews on any area of research relevant to the practice involving vascular access are welcomed. Authors are advised to specify the methodology clearly (eg, overall approach, literature search strategies, data analysis). Authors should include a structured abstract not to exceed 250 words. The main text should be structured as follows: Introduction, Aims, Methods, Results, Discussion, Conclusion, and Relevance to Clinical Practice.
Full Length Articles
Full length articles present new skills or knowledge related to vascular access and patient care, provide an empirically or clinically based review or analyze current literature related to a topic. Full length articles may review new procedures or new products.
Full length articles can also include quality improvement projects that describe a project that was carried out at the author's place of employment. The results of QI projects are not considered research manuscripts. However, QI projects should include evidence of Institutional Review Board (IRB) review if human participants were involved, and should adhere to accepted scientific standards for data collection, including evidence of measurement reliability and validity.
Case studies are detailed description of the management of a unique clinical case problem. The description of the case includes but not limited to the relevant patient characteristics, examination/ evaluation, diagnosis, and a description of the interventions that were provided.
In this unique column we ask you to share personal stories or “lessons learned” about caring for, living with, or having a vascular access device. In about 1,000 words and in conversational style, present your story. Youcan submit on behalf of someone or encourage them to write it themselves. Patient/Consumer Perspective submissions should be sent to JAVAeditor@avainfo.org as an attachment.
Letters to the Editor
Letters to the Editor are welcomed and encouraged as a form of collegial exchange. Letters must be sent to the journal and written in response to content published in JAVA within six months of the original appearance of the material. Letters should not exceed 400 words of text and include no more than three references.
For acceptance, letters must be signed. Authors must include their city and state of residence or work. No other affiliations will be included unless the authors are writing on behalf of an organization. In such cases, the authors should include a statement that the letter has been approved by the organization they are representing. A letter can appear anonymously if requested by the author. Such requests will be considered on a case-by-case basis.
A letter that questions, criticizes, or responds to a previously published article will automatically be sent to the author of that article for a reply. Authors must provide contact information to allow editors to follow up with any questions about a letter. Include city and state of residenceor work and contact information—either an e-mail address or a phone number. Letters to the Editor submissions should be sent to JAVAeditor@avainfo.org as an attachment.
Correspondence and editorial inquiries should be addressed to JAVAeditor@avainfo.org.
BEFORE YOU BEGIN
Ethics in publishing
Publication of an article in the Journal of the Association for Vascular Access (JAVA) is an integral part of the growth and development of the vascular access specialty. It is a direct reflection of the hard work by the authors, the institutions that support them and AVA. Clinical evidence and peer-reviewed articles support and magnify AVA’s mission, vision and values, while also establishing and promoting innovative conversations that push the scientific method.
It is imperative to agree upon standards of expected ethical behavior for each party involved in the completion of manuscripts and production and publication of the journal: the author, the journal editor, peer reviewers and publisher.
Plagiarism is strictly prohibited. When citing others’, or your previous own, work, ensure you have clearly marked quoted verbatim from another source with quotation marks. Attribute and reference the source of the quotation clearly within the text and in the References section.
All data must be accurate and representative of your research. If you have raw data you wish to include for publication, JAVA encourages you to provide it as a supplemental file. Authors may be contacted by the Editor to provide supporting raw data. If the author does not have the necessary information to share with the Editor and reviewers and is unable to provide a satisfactory explanation as to why, your submission will be rejected.
It is essential for authors to be declarative and honest about any conflicts of interest, whether sources of research funding, direct and indirect financial support, supply of equipment or materials or other support.
If the author fails to declare a conflict of interest to the journal upon submission, during review or at request by the journal, the paper may be rejected.
Studies in humans and animals
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.
Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments , or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978) and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study.
Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:
1. A summary declaration of interest statement in the title page file (if double-blind) or the manuscript file (if single-blind). If there are no interests to declare then please state this: 'Declarations of interest: none'. This summary statement will be ultimately published if the article is accepted.
2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously, that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder.
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Articles should make no assumptions about the beliefs or commitments of any reader, should contain nothing which might imply that one individual is superior to another on the grounds of race, sex, culture or any other characteristic, and should use inclusive language throughout. Authors should ensure that writing is free from bias, for instance by using 'he or she', 'his/her' instead of 'he' or 'his', and by making use of job titles that are free of stereotyping (e.g. 'chairperson' instead of 'chairman' and 'flight attendant' instead of 'stewardess').
All authors should have made substantial contributions to all of the following:
(1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data,
(2) drafting the article or revising it critically for important intellectual content
(3) final approval of the version to be submitted.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such achange, the Editor must receive the following from the corresponding author:
(a) the reason for the change in author list and
(b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If thefunding source(s) had no such involvement, then this should be stated.
Language (usage and editing services)
Please write your text in good English (American or British usage is accepted, but not a mixture of these).
Informed consent and patient details
Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an Allen Press publication. Written consents must be retained by the author but copies should not be provided to the journal. Only if specifically requested by the journal in exceptional circumstances (for example if a legal issue arises) the author must provide copies of the consents or evidence that such consents have been obtained. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.
Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.
Submit your article
Please submit your article via https://www.editorialmanager.com/java
JAVA is a peer-reviewed journal. Manuscripts are reviewed by the Editorial Board for accuracy, clarity, and significance to the practice of vascular access. The review process takes approximately 2-3 months. Accepted manuscripts are subject to copyediting to conform to the Journal's standards. Editorial revisions may be made to improve presentation without altering meaning. Editing changes and recommendations are subject to author approval before publication.
Proofs of the final manuscript will be sent to the principal author for approval. No significant changes will be accepted at that time. A signed contract with transfer copyright of the published article to the Association of Vascular Access is required prior to final publication. Publication dates depend on numerous factors, including the timeliness of the article and space availability in the journal. It is the responsibility of the principal author to maintain current contact information with the editorial staff. Manuscripts can be withdrawn any time prior to publication, provided that the manuscript is not in press, by notifying the editorial staff.
Permission and consents
Written permission of the copyright holder and author of figures, tables, or quotation (200 words or more) taken from copyrighted material must accompany the submitted manuscript. The credit line should appear in the figure legend, as a footnote to the table, or as a footnote to the text, and should be worded according to the copyright holder's specifications.
Subject or guardian consent must accompany any photograph that shows a recognizable likeness of a subject.
This journal operates a double blind review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of three independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final.
This journal uses double-blind review, which means the identities of the authors are concealed from the reviewers, and vice versa. To facilitate this, please include the following separately:
Title page (with author details): This should include the title, authors' names, affiliations, acknowledgements and any Declaration of Interest statement, and a complete address for the corresponding author including an e-mail address.
Blinded manuscript (no author details): The main body of the paper (including the references, figures, tables and any acknowledgements) should not include any identifying information, such as the authors' names or affiliations.
All manuscripts should be in MS Word format and conform to word length specifications. All content, including tables, should have one-inch margins on all four sides, be double-spaced, and be in Times New Roman 12 point font. All legends for Tables and Figures are to be included at the end of the manuscript, after the list of references. Tables and Figures are attached as separate files when you reach "attach files" in the submission process.
Do not include any author identifying material in the body of the manuscript. The use of jargon and unfamiliar abbreviations is discouraged. The use of headings and subheadings to organize the text is encouraged. The use of generic drug names and product descriptions should be used whenever possible. If the brand name is required to aid the readers' understanding, the manufacturer's name and city and state location are to be provided in parentheses within the text.
A cover letter introduces your manuscript to the editor and should include any specific information you would like the editor to know. Authors should state that any manuscript, or parts of it, have not been and will not be submitted elsewhere for publication.
- Title - Be concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
- Author names, credentials, and affiliations - Where the family name may be ambiguous (eg, a double name), please clearly indicate given names and surnames. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations, institutional and corporate, with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.
- Corresponding author - Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that phone numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address. Contact details must be kept up to date by the corresponding author.
- Present/permanent address - If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
- Funding - Report all funding sources and/or granting agencies that supported your work, as well as all institutional or corporate affiliations of all the authors.
- Acknowledgments - Include acknowledgments as applicable.
- Word count - Include the word count for the Abstract and the paper (excluding the Title page).
Submit the Title page separately as instructed. Do not include any author identifying material in the body of the manuscript.
Abstract and key words
An informative abstract follows the manuscript's outline and summarizes the research results (if applicable). The abstract should also be included in the main manuscript. Identify three (3) to five (5) key words related to your article. These key words help categorize your article in search engines after it is published.
If an author is interested in providing a graphical abstract (optional), please contact the editor and publisher about options available.
Highlights are mandatory for this journal. They consist of a short collection of bullet points that convey the core findings of the article and should be submitted in a separate editable file in the online submission system. Please use 'Highlights' in the file name and include 3 to 5 bullet points (maximum 85 characters, including spaces, per bullet point).
Formatting of funding sources
List funding sources in this standard way to facilitate compliance to funder's requirements:
Funding: This work was supported by the National Institutes of Health [grant numbers xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and the United States Institutes of Peace [grant number aaaa].
It is not necessary to include detailed descriptions on the program or type of grants and awards. When funding is from a block grant or other resources available to a university, college, or other research institution, submit the name of the institute or organization that provided the funding.
If no funding has been provided for the research, please include the following sentence:
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
• Make sure you use uniform lettering and sizing of your original artwork.
• Embed the used fonts if the application provides that option.
• Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, Symbol, or use fonts that look similar.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Size the illustrations close to the desired dimensions of the published version.
• Submit each illustration as a separate file.
• Please reference the Allen Press guides for Mulitmedia Preparation and Art Prep for illustrations.
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is' in the native document format.
Regardless of the application used other than Microsoft Office, when your electronic artwork is finalized, please 'Save as' or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
EPS (or PDF): Vector drawings, embed all used fonts.
TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 dpi.
TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a minimum of 1000 dpi.
TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to a minimum of 500 dpi.
Please do not:
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these typically have a low number of pixels and limited set of colors;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Slides and poor resolution photographs, illustrations, or images will not be accepted. Note that permission has been granted for use, noting by whom and where for each photograph, illustration, and image. Use of photographs, illustrations, or images that are not accompanied by full permission and/or include identifiers (eg, name badges, patient name on x-ray) will not be used.
Please make sure that artwork files are in an acceptable format (TIFF (orJPEG), EPS (or PDF) or MS Office files) and with the correct resolution.
Ensure that each illustration has a caption. Supply captions separately,not attached to the figure. A caption should comprise a brief title ( not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used.
Please submit tables as editable text and not as images. Tables can be placed either next to the relevant text in the article, or on separate page(s) at the end. Number tables consecutively in accordance with their appearance in the text and place any table notes below the table body. Be sparing in the use of tables and ensure that the data presented in them do not duplicate results described elsewhere in the article. Please avoid using vertical rules and shading in table cells.
Citation in text
Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full. Unpublished results and personal communications are not recommended in the reference list but may be mentioned in the text. If these references are included in the reference list, they should follow the standard reference style of the journal and should include a substitution of the publication date with either 'Unpublished results' or 'Personal communication'. Citation of a reference as 'in press' implies that the item has been accepted for publication.
The Editor and Editorial Review Board strongly recommends the use of a tool such as EndNote, Zotero, Mendeley Cite, or RefWorks for reference management and formatting.
Increased discoverability of research and high quality peer review are ensured by online links to the sources cited. In order to allow us to create links to abstracting and indexing services, such as Scopus, CrossRef and PubMed, please ensure that data provided in the references are correct. Please note that incorrect surnames, journal/book titles, publication year and pagination may prevent link creation. When copying references, please be careful as they may already contain errors. Use of the DOI is highly encouraged.
A DOI is guaranteed never to change, so you can use it as a permanent link to any electronic article. An example of a citation using DOI for an article not yet in an issue is: VanDecar J.C., Russo R.M., James D.E., Ambeh W.B., Franke M. (2003). Aseismic continuation of the Lesser Antilles slab beneath northeastern Venezuela. Journal of Geophysical Research, https://doi.org/10.1029/2001JB000884. Please note the format of such citations should be in the same style as all other references in the paper.
At a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (DOI, author names, dates, reference to a source publication, etc), should also be given. Web references should be included in the reference list.
This journal encourages you to cite underlying or relevant datasets in your manuscript by citing them in your text and including a data reference in your Reference List. Data references should include the following elements: author name(s), dataset title, data repository, version (where available), year, and global persistent identifier. Add [dataset] immediately before the reference so we can properly identify it as a data reference. The [dataset] identifier will not appear in your published article.
References in a special issue
Please ensure that the words 'this issue' are added to any references in the list (and any citations in the text) to other articles in the same Special Issue.
In the text, indicate references by (consecutive) superscript Arabic numerals in the order in which they appear in the text. The numerals are to be used outside periods and commas, and inside colons and semicolons, following the paraphrased or summarized reference. In the reference list, number the references in the order in which they appear in the text. Please do not use any linking programs to set up references. Authors are responsible for validating the accuracy of references and for making sure that all websites used are current and working in original and revised manuscripts. For further detail and examples you are referred to the AMA Manual of Style, A Guide for Authors and Editors, Tenth Edition, ISBN 0-978-0-19-517633-9 (see http://www.amanualofstyle.com ).
Examples of journal article references:
Smith J, Canton EM. Weight-based administration of dalteparin in obese patients. Am J Health-Syst Pharm. 2003;60(7):683-687.
(Note: If the journal does not have a volume or issue number, use the issue date.)
Hunter DJ, Hankinson SE Jr, Laden F, et al. Plasma organochlorine levels and the risk of breast cancer. N Engl J Med. 1997;337(18):1253-1258.
(Note: In the case of multiple authors, include up to six (6) authors. If there are more than six (6) authors, list the first three (3) followed by "et al." )
Examples of book and book chapter references:
Davis NM. Medical Abbreviations: 26,000 Conveniences at the Expense of Communications and Safety . 12th ed. Huntingdon Valley, PA: Neil M. Davis Associates; 2005:173.
Johannsen EC, Madoff LC. Infections of the liver and biliary system. In: Mandell GL, Bennett JC, Dolin R, eds. Mandell, Douglas, and Bennett’s: Principles and Practice of Infectious Disease. Vol 1. 6th ed. Philadelphia, PA: Elsevier; 2005:951-952.
Example of an online scholarly journal reference:
Seal A, Kerac M. Operational implications of using 2006 World Health Organization growth standards in nutrition programs: secondary data analysis. BMJ. 2007;334:733. http://www.bmj.com/cgi/content/full/334/7596/733 . Accessed April 12, 2007.
Example of dataset reference:
[dataset] Oguro M, Imahiro S, Saito S, Nakashizuka T. Mortality data for Japanese oak wilt disease and surrounding forest compositions, Mendeley Data, v1; 2015. http://dx.doi.org/10.17632/xwj98nb39r.1.
Journal abbreviations source
Journal names should be abbreviated according to the List of Title Word Abbreviations .
If an author is interested in providing a video (optional), please contact the editor and publisher about options available.
Supplementary material such as applications, images and sound clips, can be published with your article to enhance it. Submitted supplementary items are published exactly as they are received (Excel or PowerPoint files will appear as such online). Please submit your material together with the article and supply a concise, descriptive caption for each supplementary file. If you wish to make changes to supplementary material during any stage of the process, please make sure to provide an updated file. Do not annotate any corrections on a previous version. Please switch off the 'Track Changes' option in Microsoft Office files as these will appear in the published version.
1. Cover letter of submission
2. Title page (including all identifying information and word counts)
3. One double-spaced original manuscript consisting of:
- Abstract (250-word limit)
- Keywords (3 to 5)
- Article text/content (note word limits)
- List of references
- Figure, photograph, and image legend(s)
4. Copies of written permission to reproduce previously published materials and photographs, illustrations, and images of identifiable individuals or copyrights including trade names
5. Figure, photograph, and image files: each figure should constitute a separate, hi resolution file (not embedded within the manuscript text file)
Accepted manuscripts are copyedited to conform to the Journal's standards (AMA 10th ed. for general style points and references). Copy editors strive to make edits to improve presentation without altering meaning. Copyedited manuscripts containing excessive queries may be sent to the corresponding author with a request to address queries by making corrections directly to the edited manuscript (Word document), prior to pagination.
Page proofs (in PDF format) will be sent as an email attachment to the corresponding author for review. Editing changes, recommendations, and queries will be evaluated and addressed at this stage. In addition:
- Check for any font conversion and inadvertent formatting errors (math, special characters, symbols, etc.), by comparing proofs against your original document.
- Check all editorial changes to ensure the meaning of your text has not been altered. You are responsible for the accuracy of your article. Post-publication changes are costly and may not be permitted.
- If your article contains figures or tables, please review them carefully for accuracy.
- Answer all copy editor and managing editor queries (queries are located on the last page of the PDF and/or contained in annotations). If no change is required in response to a question, use the phrase ‘‘OK as set’’.
- Carefully check the spelling and order of the author names and check the degrees and affiliations for all of the authors.
Corrections may be requested and queries answered with PDF annotations made on the proofs, or by providing specific instructions (e.g., proof page, paragraph, line, “current” change to “corrected”) in a Word doc, or by describing a few simple corrections in an email. Please send corrections to the Managing Editor, Sybil Ralston (email@example.com). If any requested changes are against style, they may be edited to conform to the Journal’s style. Requested changes and answers to queries should be returned within a week of receiving proofs, unless other arrangements are made.
After an article is assigned to a specific issue, a final set of PDF proofs (with author-corrections incorporated) will be sent as an email attachment to the corresponding author for a last review. Only minor corrections should be requested at this stage. Please return any final changes to the Managing Editor within 4 business days of receiving final proofs, unless other arrangements are made.
NOTE: Additional charges will be sent to the association for revision corrections ($3.00 per revision), figure remakes (line, $14.00; halftone, $17.00; and color figures, $35.00), post-publication corrections ($300.00 per article), and the like, so we ask that you please consider these charges when submitting proof corrections. Thank you.
Manuscripts published in JAVA become the sole property of the Association for Vascular Access (AVA). Authors submitting a manuscript do so with the understanding that if it is accepted forpublication, copyright of the article will be assigned exclusively to JAVA. This copyright release gives JAVA permanent publication rights for all print and electronic media (including all alternative media currently in existence or that may be developed in thefuture) and international publication rights (including translations). JAVA will not refuse any reasonable request by the author for permission to reproduce any of his or her contributions to the journal.